期刊文献+

抗 N -甲基-D -天门冬氨酸受体脑炎57例临床分析 被引量:6

Anti-N -methyl -D -aspartate receptor encephalitis:clinical analysis of 57 cases
原文传递
导出
摘要 抗N-甲基-D-天门冬氨酸(NMDA)受体脑炎是一组免疫介导的神经精神综合征,属于自身免疫性脑炎。2007年Dalmau和Bataller首先报道了表现为神经精神症状的12例抗NMDA受体脑炎患者,均行血清或脑脊液检测,发现了抗NMDA受体抗体,依据临床上表现出的精神症状、癫痫发作、记忆障碍、意识水平下降以及低通气状态等一系列特征,称为抗NMDA受体脑炎。并明确了这类脑炎的异常靶点在NMDA受体的NRl亚基上。随着对疾病的认识和检查手段的不断丰富,近两年来,诊断为抗NMDA受体脑炎患者的数量也大量增多,本研究汇总了2013年1月~2015年11月经抗NMDA受体抗体筛查,脑脊液NMDA受体抗体阳性,伴或不伴血清NMDA受体抗体阳性,同时排除其他诊断如病毒性脑炎、脑肿瘤、代谢性疾病、药物中毒等,确诊为抗NMDA受体脑炎的非儿童患者57例。现对其临床特点进行分析,以提高对抗NMDA受体脑炎的认识。
出处 《神经疾病与精神卫生》 2016年第3期317-319,共3页 Journal of Neuroscience and Mental Health
关键词 自主神经系统 免疫疗法 畸胎瘤 抗N -甲基-D-天门冬氨酸受体脑炎 Autonomic nervous system Immunotherapy Teratoma Anti- N-methyl- D-aspartic receptor encephalitis
  • 相关文献

参考文献16

  • 1Dalmau J, Bataller L. Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications[J]. Neurologia, 2007,22 (8) :526-537.
  • 2韩太真,李延海.NMDA受体的结构与药理学特性[J].心理科学进展,2008,16(3):464-474. 被引量:33
  • 3Sansing LH, Tuzun E, Ko MW, et al. A patient with encephalitis associated with NMDA receptor antibodies[J]. Nat Clin Pratt Neurol, 2007,3(5):291-296.
  • 4Mochizuki Y, Mizutani T, Isozaki E, et al. Acute limbic encephalitis: a new entity? [J]. Neurosci Lett, 2006,394 (1) : 5-8.
  • 5Iizuka T, Sakai F, Ide T, et al. Anti- NMDA receptor encephalitis in Japan: long-term outcome without tumor removal[J]. Neurology, 2008,70(7) :504-511.
  • 6Posner JB, Dalmau J. Clinical enigmas of paraneoplastic neurologic disorders[J]. Clin Neurol Neurosurg, 1995,97 (1) : 61-70.
  • 7乔娜娜,孙若鹏.抗N-甲基-D-天门冬氨酸受体脑炎的病因学[J].中国当代儿科杂志,2014,16(6):567-570. 被引量:9
  • 8Granerod J, Ambrose HE, Davies NW, et al. Causes of en cephalitis and differences in their clinical presentations in Eng land: a multicentre, population-based prospective study[J]. Lancet Infect Dis, 2010,10(12):835-844.
  • 9Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti- NMDAR encephalitis[J]. Lancet Neurol, 2011,10 (1) : 63-74.
  • 10Barry H, Byrne S, Barrett E, et al. Anti - N- methyl- d- aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment[J]. BJPsych Bull, 2015,39 (1) : 19 - 23.

二级参考文献74

  • 1Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacological Reviews, 1999, 51(1): 7-61.
  • 2Yamakura T, Shimoji K. Subunit- and site-specific pharmacology of the NMDA receptor channel. Progress in Neurobiology, 1999, 59(3): 279-298.
  • 3Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Current Opinion in Pharmacology, 2007, 7(1): 39-47.
  • 4Yao Y, Mayer M L. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. The Journal of Neuroscience, 2006, 26(17): 4559- 4566.
  • 5Matsuda K, Kamiya Y, Matsuda S, et al. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain research. Molecular Brain Research, 2002, 100(1-2): 43-52.
  • 6Williams K. lfenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Molecular Pharmacology, 1993, 44(4): 851-859.
  • 7Paoletti P, Ascher P, Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. The Journal of Neuroscience, 1997, 17(15): 5711-5725.
  • 8Feng B, Morley R M, Jane D E, et al. The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. Neuropharmacology, 2005, 48(3): 354-359.
  • 9Liu L, Wong T P, Pozza M F, et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science, 2004, 304(5673): 1021-1024.
  • 10Neyton J, Paoletti E Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach. The Journal of Neuroscience, 2006, 26(5): 1331-1333.

共引文献40

同被引文献47

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部